ARTV Financials
Artiva Biotherapeutics Inc - Financial statements & key metrics
Stock Price
$10.80
Market Cap
$253.10M
EPS
$-3.43
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$251,000
Gross Profit
-
Operating Income
-
Net Income
$-65.37M
EPS (Diluted)
$-5.81
Balance Sheet Highlights
Total Assets
$209.58M
Total Liabilities
$22.94M
Shareholders Equity
-
Cash & Equivalents
$40.23M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-55.03M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-0.6%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ARTV revenue?
ARTV's most recent quarterly revenue was $251,000. Annual revenue can be calculated by summing the four most recent quarters.
Is ARTV profitable?
ARTV reported a loss of $65.37M in the most recent quarter.
What is ARTV market cap?
ARTV has a market capitalization of $253.10M, making it a small-cap stock.
Does ARTV have debt?
View ARTV's balance sheet for debt information.
What is ARTV cash flow?
Cash flow data is available in the full financial statements.